Armin Spura
Chief Executive Officer at CROWN BIOSCIENCE INTERNATIONAL
Profile
Armin Spura is associated with Crown Bioscience, Inc. and Crown Bioscience International as their Chief Executive Officer since 2020.
Armin Spura active positions
| Companies | Position | Start |
|---|---|---|
| CROWN BIOSCIENCE INTERNATIONAL | Chief Executive Officer | 01/04/2020 |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Chief Executive Officer | 01/04/2020 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Crown Bioscience International
 Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Armin Spura
